Results
|
|
1341.
|
|
|
|
1342.
|
|
|
|
1343.
|
|
|
|
1344.
|
|
|
|
1345.
|
|
|
|
1346.
|
|
|
|
1347.
|
Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria. [electronic resource] by
- Ockenhouse, C F
- Sun, P F
- Lanar, D E
- Wellde, B T
- Hall, B T
- Kester, K
- Stoute, J A
- Magill, A
- Krzych, U
- Farley, L
- Wirtz, R A
- Sadoff, J C
- Kaslow, D C
- Kumar, S
- Church, L W
- Crutcher, J M
- Wizel, B
- Hoffman, S
- Lalvani, A
- Hill, A V
- Tine, J A
- Guito, K P
- de Taisne, C
- Anders, R
- Ballou, W R
Producer: 19980618
In:
The Journal of infectious diseases vol. 177
Availability: No items available.
|
|
|
1348.
|
|
|
|
1349.
|
|
|
|
1350.
|
|
|
|
1351.
|
|
|
|
1352.
|
|
|
|
1353.
|
A preliminary evaluation of nelfinavir mesylate, an inhibitor of human immunodeficiency virus (HIV)-1 protease, to treat HIV infection. [electronic resource] by
- Markowitz, M
- Conant, M
- Hurley, A
- Schluger, R
- Duran, M
- Peterkin, J
- Chapman, S
- Patick, A
- Hendricks, A
- Yuen, G J
- Hoskins, W
- Clendeninn, N
- Ho, D D
Producer: 19980618
In:
The Journal of infectious diseases vol. 177
Availability: No items available.
|
|
|
1354.
|
|
|
|
1355.
|
|
|
|
1356.
|
|
|
|
1357.
|
|
|
|
1358.
|
|
|
|
1359.
|
|
|
|
1360.
|
|